WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

EXTENT OF OFF-LABEL PRESCRIPTION IN CHILDREN

Valentina B. Petkova* and Vesela Karamisheva

ABSTRACT

It has been found that newborn babies receive the most off-label. Pediatric patients make up a large part of the population that requires rational drug therapy. The aim of the study is to assess the extent of off-label prescription in children. In order to achieve the set goal, the following tasks were set: study of prescriptions in a pharmacy for outpatient care for the pediatric population and analysis of prescriptions in terms of dosage, purpose, ATC code and method of administration. The results show that the category of drugs prescribed off-label includes drugs with ATC code R - respiratory system, D-dermatological agents and N-nervous system, respectively 8%. Some of the most common off-label prescriptions are: change in dosage by grinding tablets and taking some of the powder obtained, splitting of film-coated tablets, taking part of a factory-poured suppository, using only part of the capsule contents. The results of the study confirmed the conclusions of the literature review, namely that pediatric patients are subject to off-label prescribing. The main reason for these problems is the lack of medicinal products designed specifically for the pediatric population, which requires modification of the permitted indications.

Keywords: off-label, children, neonates.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More